{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:57:33Z","timestamp":1780091853786,"version":"3.54.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.neuropharm.2021.108724","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T02:21:15Z","timestamp":1626488475000},"page":"108724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Sustained treatment with an \u03b15 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3678-9907","authenticated-orcid":false,"given":"Jessica L.","family":"Nuwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-8391","authenticated-orcid":false,"given":"Nadya V.","family":"Povysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tija C.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108724_bib1","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1523\/JNEUROSCI.5531-08.2009","article-title":"NMDA receptor GluN2B (GluR epsilon 2\/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses","volume":"29","author":"Akashi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3565(24)34997-3","article-title":"Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties","volume":"290","author":"Araujo","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108724_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2009.09.001","article-title":"Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA","volume":"125","author":"Atack","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2021.108724_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2174\/156802611795371314","article-title":"GABAA receptor subtype-selective modulators. II. alpha5-selective inverse agonists for cognition enhancement","volume":"11","author":"Atack","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108724_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","article-title":"L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors","volume":"51","author":"Atack","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108724_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/jpet.109.157636","article-title":"In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)- pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist","volume":"331","author":"Atack","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108724_bib7","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/dmd.105.006973","article-title":"Rat pharmacokinetics and pharmacodynamics OF a sustained release formulation OF the GABAA \u03b15-SELECTIVE compound L-655,708","volume":"34","author":"Atack","year":"2006","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.neuropharm.2021.108724_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186147","article-title":"Functional characterization of GABAA receptor-mediated modulation of cortical neuron network activity in microelectrode array recordings","volume":"12","author":"Bader","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108724_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000072845","article-title":"Understanding fragile X syndrome: insights from animal models","volume":"100","author":"Bakker","year":"2003","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.neuropharm.2021.108724_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-008-1357-7","article-title":"RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors","volume":"202","author":"Ballard","year":"2009","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2021.108724_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(02)00776-6","article-title":"Subunit-specific NMDA receptor trafficking to synapses","volume":"35","author":"Barria","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108724_bib12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neuron.2007.07.035","article-title":"Rapid bidirectional switching of synaptic NMDA receptors","volume":"55","author":"Bellone","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108724_bib13","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","article-title":"GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations","volume":"87","author":"Ben-Ari","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108724_bib14","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1152\/jn.00482.2007","article-title":"Alpha5GABAA receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons","volume":"98","author":"Bonin","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108724_bib15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/dneu.22280","article-title":"Synaptic localization of alpha5 GABA (A) receptors via gephyrin interaction regulates dendritic outgrowth and spine maturation","volume":"75","author":"Brady","year":"2015","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.neuropharm.2021.108724_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cne.10102","article-title":"Intact sorting, targeting, and clustering of gamma-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro","volume":"443","author":"Brunig","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108724_bib17","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/s41386-020-0772-2","article-title":"Mechanisms associated with the antidepressant-like effects of L-655,708","volume":"45","author":"Bugay","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108724_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094037","article-title":"PSD95 suppresses dendritic arbor development in mature hippocampal neurons by occluding the clustering of NR2B-NMDA receptors","volume":"9","author":"Bustos","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108724_bib19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ijnp\/pyx003","article-title":"Selective pharmacological augmentation of hippocampal activity produces a sustained antidepressant-like response without abuse-related or psychotomimetic effects","volume":"20","author":"Carreno","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2021.108724_bib20","article-title":"Functional role of ambient GABA in refining neuronal circuits early in postnatal development","volume":"7","author":"Cellot","year":"2013","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2021.108724_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2017.07.027","article-title":"Physiological and pharmacological properties of inhibitory postsynaptic currents mediated by \u03b15\u03b21\u03b32, \u03b15\u03b22\u03b32 and \u03b15\u03b23\u03b32 GABAA receptors","volume":"125","author":"Chen","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108724_bib22","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib23","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108724_bib24","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1016\/j.celrep.2019.02.070","article-title":"Nanoscale subsynaptic domains underlie the organization of the inhibitory synapse","volume":"26","author":"Crosby","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108724_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1471-4159.2001.00551.x","article-title":"Prevalence between different alpha subunits performing the benzodiazepine binding sites in native heterologous GABA(A) receptors containing the alpha2 subunit","volume":"79","author":"del Rio","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108724_bib26","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1523\/JNEUROSCI.2744-07.2007","article-title":"Sequential postsynaptic maturation governs the temporal order of GABAergic and glutamatergic synaptogenesis in rat embryonic cultures","volume":"27","author":"Deng","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib27","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1073\/pnas.0609307104","article-title":"PSD-95 is required for activity-driven synapse stabilization","volume":"104","author":"Ehrlich","year":"2007","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2021.108724_bib28","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1523\/JNEUROSCI.3567-14.2015","article-title":"GluN2B-Containing NMDA receptors regulate AMPA receptor traffic through anchoring of the synaptic proteasome","volume":"35","author":"Ferreira","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib29","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/npp.2015.112","article-title":"Rapid antidepressant action and restoration of excitatory synaptic strength after chronic stress by negative modulators of alpha5-containing GABAA receptors","volume":"40","author":"Fischell","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108724_bib30","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1523\/JNEUROSCI.4751-07.2008","article-title":"Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus?","volume":"28","author":"Glykys","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib31","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1152\/jn.01122.2005","article-title":"Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor alpha5 subunit-deficient mice","volume":"95","author":"Glykys","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108724_bib32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1113\/jphysiol.2007.134460","article-title":"The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus","volume":"582","author":"Glykys","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108724_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2014.10.004","article-title":"Benzodiazepine-dependent stabilization of GABA(A) receptors at synapses","volume":"63","author":"Gouzer","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib34","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.neuron.2011.08.007","article-title":"Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo","volume":"71","author":"Gray","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108724_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuroscience.2013.10.077","article-title":"GABA-induced uncoupling of GABA\/benzodiazepine site interactions is mediated by increased GABAA receptor internalization and associated with a change in subunit composition","volume":"257","author":"Gutierrez","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108724_bib36","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1111\/ejn.12682","article-title":"The glutamate receptor GluN2 subunit regulates synaptic trafficking of AMPA receptors in the neonatal mouse brain","volume":"40","author":"Hamada","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib37","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1038\/ncomms7872","article-title":"Radixin regulates synaptic GABAA receptor density and is essential for reversal learning and short-term memory","volume":"6","author":"Hausrat","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108724_bib38","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1038\/s41598-021-87307-7","article-title":"Basmisanil, a highly selective GABAA-\u03b15 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man","volume":"11","author":"Hipp","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2021.108724_bib39","doi-asserted-by":"crossref","first-page":"10469","DOI":"10.1523\/JNEUROSCI.2267-05.2005","article-title":"Gephyrin regulates the cell surface dynamics of synaptic GABAA receptors","volume":"25","author":"Jacob","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib40","doi-asserted-by":"crossref","first-page":"18595","DOI":"10.1073\/pnas.1204994109","article-title":"Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition","volume":"109","author":"Jacob","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108724_bib41","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1073\/pnas.0903943106","article-title":"GABA(A) receptor membrane trafficking regulates spine maturity","volume":"106","author":"Jacob","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2021.108724_bib42","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/jnr.21991","article-title":"Distinct properties of murine \u03b15 \u03b3-aminobutyric acid type a receptors revealed by biochemical fractionation and mass spectroscopy","volume":"87","author":"Ju","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108724_bib43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrn3819","article-title":"Cation-chloride cotransporters in neuronal development, plasticity and disease","volume":"15","author":"Kaila","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neulet.2007.02.058","article-title":"Increase in AMPA receptor-mediated miniature EPSC amplitude after chronic NMDA receptor blockade in cultured hippocampal neurons","volume":"418","author":"Kato","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108724_bib45","first-page":"1","article-title":"Translational mouse models of autism: advancing toward pharmacological therapeutics","volume":"28","author":"Kazdoba","year":"2016","journal-title":"Current topics in behavioral neurosciences"},{"key":"10.1016\/j.neuropharm.2021.108724_bib46","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.neuron.2005.04.031","article-title":"Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking","volume":"46","author":"Kim","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108724_bib47","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0896-6273(03)00645-7","article-title":"The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1","volume":"40","author":"Krapivinsky","year":"2003","journal-title":"Neuron"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2021.108724_bib48","doi-asserted-by":"crossref","first-page":"i73","DOI":"10.1093\/bja\/aet038","article-title":"Potentiation of GABAA receptor activity by volatile anaesthetics is reduced by alpha5GABAA receptor-preferring inverse agonists","volume":"110","author":"Lecker","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2021.108724_bib49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuropharm.2014.06.002","article-title":"Benzodiazepine ligands rapidly influence GABAA receptor diffusion and clustering at hippocampal inhibitory synapses","volume":"88","author":"L\u00e9vi","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108724_bib50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fnbeh.2015.00300","article-title":"Assessment of cognitive scales to examine memory, executive function and language in individuals with down syndrome: implications of a 6-month observational study","volume":"9","author":"Liogier d'Ardhuy","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib51","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0169-328X(98)00144-2","article-title":"The alpha5 subunit of the murine type A GABA receptor","volume":"59","author":"Liu","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuropharm.2021.108724_bib52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fncel.2019.00163","article-title":"Diazepam accelerates GABAAR synaptic exchange and alters intracellular trafficking","volume":"13","author":"Lorenz-Guertin","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0028-3908(01)00188-5","article-title":"Functional expression of distinct NMDA channel subunits tagged with green fluorescent protein in hippocampal neurons in culture","volume":"42","author":"Luo","year":"2002","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2021.108724_bib54","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bja.2020.11.032","article-title":"Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of \u03b15 subunit-containing \u03b3-aminobutyric acid type A receptors: implications for treating cognitive deficits","volume":"126","author":"Manzo","year":"2020","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2021.108724_bib55","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1021\/acs.jmedchem.9b01312","article-title":"Subtype selective \u03b3-aminobutyric acid type A receptor (GABAAR) modulators acting at the benzodiazepine binding site: an update","volume":"63","author":"Maramai","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108724_bib56","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1042\/BST0371334","article-title":"The physiological properties and therapeutic potential of alpha5-GABAA receptors","volume":"37","author":"Martin","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2021.108724_bib57","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1523\/JNEUROSCI.4209-09.2010","article-title":"Alpha5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory","volume":"30","author":"Martin","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib58","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1523\/JNEUROSCI.1203-12.2013","article-title":"Reducing GABAA alpha5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome","volume":"33","author":"Martinez-Cue","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ntt.2016.10.009","article-title":"Reduced expression of alpha5GABAA receptors elicits autism-like alterations in EEG patterns and sleep-wake behavior","volume":"61","author":"Mesbah-Oskui","year":"2017","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2021.108724_bib60","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41380-018-0100-y","article-title":"Diazepam-induced loss of inhibitory synapses mediated by PLC\u03b4\/Ca2+\/calcineurin signalling downstream of GABAA receptors","volume":"23","author":"Nicholson","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108724_bib61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function","volume":"60","author":"Olsen","year":"2008","journal-title":"Update. Pharmacol Rev"},{"key":"10.1016\/j.neuropharm.2021.108724_bib62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108724_bib63","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn0901-917","article-title":"Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons","volume":"4","author":"Passafaro","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2016.08.006","article-title":"Effects of memantine on the excitation-inhibition balance in prefrontal cortex","volume":"96","author":"Povysheva","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108724_bib65","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/7263","article-title":"Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo","volume":"2","author":"Quinlan","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib66","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0028-3908(96)00061-5","article-title":"[3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the alpha 5 subunit","volume":"35","author":"Quirk","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108724_bib67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.devbrainres.2004.04.003","article-title":"Expression of alpha 5 GABAA receptor subunit in developing rat hippocampus","volume":"151","author":"Ramos","year":"2004","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.neuropharm.2021.108724_bib68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/16697","article-title":"The K+\/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation","volume":"397","author":"Rivera","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108724_bib69","doi-asserted-by":"crossref","first-page":"13341","DOI":"10.1523\/JNEUROSCI.3277-07.2007","article-title":"Activity-dependent ubiquitination of GABA(A) receptors regulates their accumulation at synaptic sites","volume":"27","author":"Saliba","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fncel.2020.00036","article-title":"Depolarizing GABA transmission restrains activity-dependent glutamatergic synapse formation in the developing hippocampal circuit","volume":"14","author":"Salmon","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib71","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2021.108724_bib72","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2021.108724_bib73","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/s41467-018-06004-8","article-title":"Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear \u03b15-GABAA receptors","volume":"9","author":"Schulz","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108724_bib74","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1523\/JNEUROSCI.2723-18.2019","article-title":"Enhanced dendritic inhibition and impaired NMDAR activation in a mouse model of down syndrome","volume":"39","author":"Schulz","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib75","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1152\/jn.00823.2009","article-title":"Differential roles of NMDA Receptor Subtypes NR2A and NR2B in dendritic branch development and requirement of RasGRF1","volume":"103","author":"Sepulveda","year":"2010","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108724_bib76","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1523\/JNEUROSCI.21-16-06233.2001","article-title":"Developmental depression of glutamate neurotransmission by chronic low-level activation of NMDA receptors","volume":"21","author":"Shi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib77","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1124\/mol.54.5.928","article-title":"Rat and human hippocampal alpha5 subunit-containing gamma-aminobutyric AcidA receptors have alpha5 beta3 gamma2 pharmacological characteristics","volume":"54","author":"Sur","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108724_bib78","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/sj.emboj.7600151","article-title":"Developmentally regulated role for Ras-GRFs in coupling NMDA glutamate receptors to Ras, Erk and CREB","volume":"23","author":"Tian","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2021.108724_bib79","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1523\/JNEUROSCI.5050-07.2008","article-title":"The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor alpha 2 subunits to gephyrin","volume":"28","author":"Tretter","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib80","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2009.11.005","article-title":"alpha5 Subunit-containing GABA(A) receptors mediate a slowly decaying inhibitory synaptic current in CA1 pyramidal neurons following Schaffer collateral activation","volume":"58","author":"Vargas-Caballero","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108724_bib81","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1523\/JNEUROSCI.5599-07.2008","article-title":"GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108724_bib82","doi-asserted-by":"crossref","first-page":"11412","DOI":"10.1073\/pnas.0806037105","article-title":"GABAA transmission is a critical step in the process of triggering homeostatic increases in quantal amplitude","volume":"105","author":"Wilhelm","year":"2008","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2021.108724_bib83","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0896-6273(93)90317-K","article-title":"Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro","volume":"10","author":"Williams","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108724_bib84","doi-asserted-by":"crossref","first-page":"108899","DOI":"10.1016\/j.celrep.2021.108899","article-title":"Activity- and sleep-dependent regulation of tonic inhibition by Shisa7","volume":"34","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108724_bib85","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/ejp.1009","article-title":"Inhibition of \u03b15 subunit-containing GABA(A) receptors facilitated spinal nociceptive transmission and plasticity","volume":"21","author":"Xue","year":"2017","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2021.108724_bib86","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.neuropharm.2008.07.046","article-title":"Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity","volume":"55","author":"Yashiro","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108724_bib87","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1038\/ncomms4230","article-title":"A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages","volume":"5","author":"Yu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108724_bib88","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0285-16.2017","article-title":"A negative allosteric modulator for alpha5 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice","volume":"4","author":"Zanos","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2021.108724_bib89","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/jn.91203.2008","article-title":"GABAA receptor {alpha}5 subunits contribute to GABAA,slow synaptic inhibition in mouse Hippocampus","volume":"101","author":"Zarnowska","year":"2009","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108724_bib90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/acn3.303","article-title":"alpha5GABAA receptor deficiency causes autism-like behaviors","volume":"3","author":"Zurek","year":"2016","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821002793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821002793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:13:31Z","timestamp":1758438811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821002793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":90,"alternative-id":["S0028390821002793"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108724","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained treatment with an \u03b15 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108724"}}